HUMANITARIAN OF THE YEAR, CCHR
Stephen Sheller was honored as “Humanitarian of the Year” by the Citizens Commission on Human Rights (CCHR). The black tie event was held at the Los Angeles Westin Bonaventure February 28, 2015. The introduction to his award: “CCHR’s first human rights award winner is a renowned attorney Stephen Sheller. His Philadelphia law firm opposes some […]
J&J Loses Trial Over Risperdal and Male Breast
The Wall Street Journal Pharmalot Blog 2015-02-24 In a setback to Johnson & Johnson, a Philadelphia jury decided the health care giant must pay $2.5 million in damages for failing to warn that its Risperdal antipsychotic could cause gynecomastia, which is abnormal development of breasts in males. The lawsuit was brought by the family of […]
Legal Intelligencer Quotes Sheller on Risperdal Suit Filings
The Legal Intelligencer 2014-01-15 Individual suit filings related to the antipsychotic drug Risperdal have been increasing in the Philadelphia Court of Common Pleas, First Judicial District leaders say. The uptick has been steady since actions against Johnson & Johnson and its subsidiaries began four years ago, according to the court officials. “We have a group […]
Sheller Presents on Whistleblower Qui Tam at Bench Bar 2014
2014-09-30 Stephen Sheller presented the feature CLE “American ‘Hustle’: Whistleblowers and Prosecuting False Claims Act Cases” at the Montgomery County Bench Bar conference September 2014. Joined by former Assistant U.S. Attorney Joseph Trautwein, they addressed the complexity of bringing and defending False Claims Act matters by analyzing case developments including their most recent $7.3 million […]
Sheller Quoted in “Dangers of Off-Label Drug Use Kept Secret”
The Toronto Star 2014-06-26 By: David Bruser News Reporter, Jesse McLean Investigative News reporter, Andrew Bailey Data Analyst, Published on Thu Jun 26 2014 A 15-year-old girl who wanted to clear her acne was prescribed the antibiotic minocycline. The teen developed lupus-like symptoms — her immune system attacked her own tissues and organs — and she died. The drug was not approved […]
$7.3M Astellas Pharma Off-Label Marketing and FCA Settlement
Digital Journal 2014-04-16 The whistleblower attorney team of Sheller P.C. announced today that Astellas Pharma U.S., Inc. has agreed to pay $7.3 million to resolve allegations by the Sheller whistleblower client that Astellas violated the False Claims Act by submitting fraudulent claims to government healthcare programs while marketing off-label the antifungal drug Mycamine for use in children. Court […]
Legal Intelligencer Quotes Sheller on Low T Drug Cases
Law.com 2014-03-04 Several products liability attorneys say that the recent appearance of lawsuits nationwide against the manufacturers of testosterone therapy drugs indicates the potential for multidistrict litigation and possibly a new mass tort. Many of the current suits filed in federal courts across the country are against Abbott Laboratories—maker of the topical testosterone therapy drug […]
Sheller Gift Supports Drexel Health Center Expansion and Mission
DrexelNOW 2014-02-21 Drexel University will begin a major expansion of its nurse-managed health center which is nationally recognized as a model of integrated care. With a new gift of $2.5 million from the Sheller Family Foundation, the center at 850 N. 11th Street will break ground for a new wing this spring, with the expanded […]
Sheller Whistleblower Settlement: Florida Pain Practice Pays $750,000
2014-02-25 Sheller, P.C. announced today that Sarasota Pain Associates, P.A. (SPA) and its owner, Dr. Steven Chun, have agreed to pay $750,000 to resolve allegations by the law firm’s whistleblower clients that SPA violated the False Claims Act by submitting false claims to Medicare for procedures and services that he did not perform. During the time […]
Sheller Six Risperdal Settlements, Hundreds More Boys Represented
